{"title":"Models of Best Practice: Nurse Integration Into the BRCA1/BRCA2 Testing Pathway.","authors":"","doi":"10.1188/24.CJON.575-581","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Genetic testing for heritable germline variants in BRCA1/BRCA2 genes informs risk assessment and treatment decisions and often involves a non-nursing oncology multidisciplinary team, which offers pretest counseling, obtains patient consent, and arranges genetic testing.</p><p><strong>Objectives: </strong>This review, initiated by a collaboration of international nurses, summarizes the potential roles of oncology nurses in the genetic testing pathway, including germline BRCA testing.</p><p><strong>Methods: </strong>Literature discussing nurses' roles in germline BRCA testing and genomic testing in general was screened, which resulted in 33 studies being selected for further analysis.</p><p><strong>Findings: </strong>The literature demonstrates the value of nurses obtaining patient consent and samples and providing pre- and post-test counseling and follow-up care, which can help to improve wait times and educate patients about their cancer risks to make informed healthcare decisions. Nurses mostly felt that genetic testing did not negatively affect their workloads. Concerns over nonspecialists delivering pretest counseling exist, and specialized training is required, although patients were satisfied with the information nurses provided.</p>","PeriodicalId":10350,"journal":{"name":"Clinical journal of oncology nursing","volume":"28 6","pages":"575-581"},"PeriodicalIF":1.2000,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical journal of oncology nursing","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1188/24.CJON.575-581","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NURSING","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Genetic testing for heritable germline variants in BRCA1/BRCA2 genes informs risk assessment and treatment decisions and often involves a non-nursing oncology multidisciplinary team, which offers pretest counseling, obtains patient consent, and arranges genetic testing.
Objectives: This review, initiated by a collaboration of international nurses, summarizes the potential roles of oncology nurses in the genetic testing pathway, including germline BRCA testing.
Methods: Literature discussing nurses' roles in germline BRCA testing and genomic testing in general was screened, which resulted in 33 studies being selected for further analysis.
Findings: The literature demonstrates the value of nurses obtaining patient consent and samples and providing pre- and post-test counseling and follow-up care, which can help to improve wait times and educate patients about their cancer risks to make informed healthcare decisions. Nurses mostly felt that genetic testing did not negatively affect their workloads. Concerns over nonspecialists delivering pretest counseling exist, and specialized training is required, although patients were satisfied with the information nurses provided.
期刊介绍：
The Clinical Journal of Oncology Nursing (CJON) is an official publication of the Oncology Nursing Society (ONS) and is directed to the practicing nurse specializing in the care of patients with an actual or potential diagnosis of cancer. CJON is a vehicle to promote the mission of ONS, which is to advance excellence in oncology nursing and quality cancer care. The CJON mission is twofold: to provide practical information necessary to care for patients and their families across the cancer continuum and to develop publication skills in oncology nurses.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
